Globestar Therapeutics Corp (GSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 7 | 13 | 3 | 19 | 15 |
| Total expenses | 250 | 220 | 153 | 117 | 61 |
| Operating Income | -243 | -207 | -150 | -98 | -46 |
| Interest Expense | 46 | 60 | 154 | 127 | 169 |
| Pre-tax Income | -289 | -267 | -304 | -226 | -216 |
| Net Income Continuous | -289 | -267 | -304 | -226 | -216 |
| Net Income | $-289 | $-267 | $-304 | $-226 | $-216 |
| EPS Basic Continuous Ops | 1.92 | -0.76 | -0.98 | -0.84 | -4.58 |
| EPS Basic Total Ops | 1.92 | -0.76 | -0.98 | -0.84 | -4.58 |
| EPS Diluted Continuous Ops | 1.92 | -0.76 | -0.98 | -0.84 | -4.58 |
| EPS Diluted Total Ops | 1.92 | -0.76 | -0.98 | -0.84 | -4.58 |
| EBITDA(a) | $-214 | $-156 | $-8 | $16 | $70 |